Mark E. Dmytruk Ginkgo Bioworks Holdings, Inc. (DNA) insider trading activity

Mark E. Dmytruk is Officer of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 46,226 shares of DNA, which is worth approximately $525,127. The most recent transaction as insider was on May 02, 2023, when has been sold 38,802 shares (Class A Common Stock) at a price of $1.15 per share, resulting in proceeds of $44,622. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.2K

4.7% 3M change

95.57% 12M change

Total Value Held $525,127

Mark E. Dmytruk Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 02 2023	SELL Open market or private sale	$44,622 $1.15 p/Share	38,802 Reduced 5.87%	622,495 Class A Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	-	85,043 Added 11.39%	661,297 Class A Common Stock
Apr 10 2023	SELL Open market or private sale	$984 $1.33 p/Share	740 Reduced 0.13%	576,254 Class A Common Stock
Apr 06 2023	BUY Exercise of conversion of derivative security	-	1,636 Added 0.28%	576,994 Class A Common Stock
Apr 03 2023	SELL Open market or private sale	$49,259 $1.27 p/Share	38,787 Reduced 6.32%	575,358 Class A Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	-	83,409 Added 11.96%	614,145 Class A Common Stock
Mar 15 2023	SELL Open market or private sale	$38,988 $1.31 p/Share	29,762 Reduced 5.31%	530,736 Class A Common Stock
Mar 14 2023	BUY Exercise of conversion of derivative security	-	65,281 Added 10.43%	560,498 Class A Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	1,635 Added 0.33%	495,217 Class A Common Stock
Feb 02 2023	SELL Open market or private sale	$59,961 $2.15 p/Share	27,889 Reduced 5.35%	493,582 Class A Common Stock
Feb 01 2023	BUY Exercise of conversion of derivative security	-	66,922 Added 11.37%	521,471 Class A Common Stock
Jan 04 2023	SELL Open market or private sale	$53,957 $1.56 p/Share	34,588 Reduced 7.07%	454,549 Class A Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	-	68,582 Added 12.3%	489,137 Class A Common Stock
Dec 02 2022	SELL Open market or private sale	$58,397 $1.94 p/Share	30,102 Reduced 6.68%	420,555 Class A Common Stock
Dec 01 2022	BUY Exercise of conversion of derivative security	-	66,583 Added 12.87%	450,657 Class A Common Stock
Nov 03 2022	SELL Open market or private sale	$80,794 $2.64 p/Share	30,604 Reduced 7.38%	384,074 Class A Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	-	66,589 Added 13.84%	414,678 Class A Common Stock
Oct 06 2022	SELL Open market or private sale	$907,579 $3.25 p/Share	279,255 Reduced 44.51%	348,089 Class A Common Stock
Oct 05 2022	BUY Exercise of conversion of derivative security	-	618,242 Added 49.63%	627,344 Class A Common Stock
Oct 03 2022	SELL Open market or private sale	$22,648 $3.12 p/Share	7,259 Reduced 44.37%	9,102 Class A Common Stock
Sep 30 2022	BUY Exercise of conversion of derivative security	-	16,361 Added 50.0%	16,361 Class A Common Stock

MED

Mark E. Dmytruk

Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Value

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA

Account